Le Lézard
Classified in: Health
Subjects: GOVERNMENT CONTRACTS, Contests/Awards

"Cutest Pets on Parliament Hill" Photo Contest: Politics and Pets Collide


TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- In a celebration of the importance of furry companionship amidst the hustle and bustle of Canadian politics, the Canadian Animal Health Institute is thrilled to announce the launch of our second annual "Cutest Pets on Parliament Hill" photo contest!

This unique contest invites parliamentarians, staffers, members of the press gallery, and those with direct ties to the Hill to showcase their beloved pets for a chance to be crowned cutest on the Hill.

"We're excited to bring a touch of whimsy and warmth to Parliament Hill with the return of our Cutest Pets on Parliament Hill photo contest," said Dr. Filejski, CEO of the Canadian Animal Health Institute. "We can't wait to see the incredible diversity of pets and personalities that grace Parliament Hill. Whether they have paws, hooves, fur, feathers, or scales, each pet brings something special to the table, and we're thrilled to shine a spotlight on the important role they play in our lives."

Between now and May 3rd MPs, Senators, staffers, members of the press gallery, and all those working on the Hill are encouraged to submit a photo of their beloved pet for a chance to be crowned the ?Cutest Pet on Parliament Hill', a title which comes with bragging rights for a whole year. A panel of esteemed judges will select the top ten entries based on criteria including overall cuteness, creativity, personality (i.e. a fun bio), and a connection to Canada.

Once the top 10 finalists in each category are selected, the selection process will then turn over to the public for their votes! The pet with the most votes in each category: Dog, Cat and Other Pet, will be crowned at a special ceremony in Ottawa on June 11th.

May the cutest pet win!

For contest details please visit www.cahi-icsa.ca.

About the CAHI
Established in 1968, CAHI is the trusted, science-based voice of the Canadian animal health industry. Our members provide Canada's veterinarians and animal owners with the animal medications and tools necessary to maintain the health of our pets and food animal population. Healthier animals for a healthier Canada. www.cahi-icsa.ca.

Contact : Eleanor Hawthorn, Communications Manager
437-253-1667 ext, 105 [email protected]



These press releases may also interest you

at 22:00
Subang Jaya Medical Centre Applauded by Frost & Sullivan as the Best Hospital Company of the Year in Malaysia for the fourth consecutive year
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

at 20:14
Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of IBI363 (PD-1/IL-2) and IBI343 (CLDN18.2 ADC)
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP agilon health, inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm (AGL)
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines' ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

More news about Health...


News published on and distributed by: